H2020 Accelerator Program Live Biotherapeutics Manufacturing
Aug 3, 2020

Exeliom Biosciences has been awarded a 2.5M€ H2020 Accelerator Program Grant from the European Innovation Council

This very selective grant will help Exeliom Biosciences obtain first clinical readouts and achieve the manufacturing process scale-up, while protecting its proprietary know-how. With this EIC support, Exeliom Biosciences will be able to greatly accelerate its promising drug development and growth.

Back to news


Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.